Hashim Zaibak, PharmD

home / authors / hashim-zaibak-pharmd

Founder and CEO of Hayat Pharmacy in southeastern Wisconsin

Articles

Immunization Services Paramount for Community Pharmacy Sustainability

Immunization Services Paramount for Community Pharmacy Sustainability

Brian Nowosielski;Hashim Zaibak, PharmD
August 15th 2025

During National Immunization Awareness Month, Hashim Zaibak, PharmD, provided personal tips for community pharmacies looking to expand their vaccination services.

Community Pharmacy’s Pivotal Role in Boosting Immunization Rates

Community Pharmacy’s Pivotal Role in Boosting Immunization Rates

Brian Nowosielski;Hashim Zaibak, PharmD
August 7th 2025

As researchers continue to measure the impacts of the COVID-19 pandemic on public health, Hashim Zaibak, PharmD, discusses the evolution of community pharmacies in a postpandemic world.

Pharmacy Training Crucial for Addressing Distrust in Vaccines

Pharmacy Training Crucial for Addressing Distrust in Vaccines

Brian Nowosielski;Hashim Zaibak, PharmD
August 4th 2025

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discusses the ongoing narratives surrounding vaccine hesitancy as well as his thoughts on the best ways of addressing the phenomenon.

Q&A: Community Pharmacies Help Increase Immunization Convenience, Uptake

Q&A: Community Pharmacies Help Increase Immunization Convenience, Uptake

Brian Nowosielski;Hashim Zaibak, PharmD
August 3rd 2025

Hashim Zaibak, PharmD, CEO of Hayat Pharmacy, discusses how immunization services at his pharmacy locations have evolved since the COVID-19 pandemic.

Latest Updated Articles

CVS, Walgreens Will Limit COVID-19 Vaccine Offerings in 16 States
Published: September 2nd 2025 | Updated: September 5th 2025
CVS, Walgreens Will Limit COVID-19 Vaccine Offerings in 16 States
In This Issue: Total Pharmacy August 2024
Published: August 6th 2024 | Updated: August 20th 2024
In This Issue: Total Pharmacy August 2024
SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease
Published: July 8th 2024 | Updated: July 10th 2024
SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease
Transitions of Care and Unmet Needs in Hyperkalemia Management
Published: September 3rd 2025 | Updated: September 19th 2025
Transitions of Care and Unmet Needs in Hyperkalemia Management
Examining the Interplay Between Guideline-Directed Medical Therapy and Hyperkalemia
Published: August 27th 2025 | Updated: September 19th 2025
Examining the Interplay Between Guideline-Directed Medical Therapy and Hyperkalemia
Discussing the Chronic Treatment Options for Hyperkalemia
Published: August 20th 2025 | Updated: September 19th 2025
Discussing the Chronic Treatment Options for Hyperkalemia
© 2025 MJH Life Sciences

All rights reserved.